Evidence map›Paper›PMID 42859796›Full record

ArticleCureus2026

Trimodal Therapy for Primary Squamous Cell Carcinoma of the Vagina: A Case Report.

Jake Singh, Thomas R Eanelli

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jake SinghRadiation Oncology, Touro College of Osteopathic Medicine, Middletown, USA.
Thomas R EanelliRadiation Oncology, Garnet Health, Middletown, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary vaginal squamous cell carcinoma (SCC) is a rare clinical entity, with few prospective studies regarding its treatment available in the literature. We report a case of a 64-year-old female patient with a two-year history of vulvar itching, burning, and intermittent vulvar bleeding. She was diagnosed with stage III (T2, N1, M0) vaginal SCC. The patient subsequently received chemotherapy with cisplatin, external beam radiation therapy (EBRT), as well as high-dose-rate (HDR) cylinder brachytherapy. She achieved a complete clinical and radiographic response, with no evidence of disease on examination or post-treatment PET at six-month follow-up. This case highlights a multimodal treatment approach for advanced vaginal SCC and contributes to the limited body of literature guiding management of this rare malignancy.

Indexed as

brachytherapyexternal beam radiation therapygynecologic malignancyhigh-dose-rate (hdr) brachytherapyvaginal squamous cell carcinoma

Identifiers

PMID42859796
PMCPMC13653533

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.